Back to results
US 11,534,479 B2Granted
Use of interleukin 2 for treating Sjögren's syndrome
AssigneesIltoo Pharma, Assistance Publique-Hopitaux de Paris, Sorbonne Universite
InventorsDavid Klatzmann, Roberta Lorenzon, Michèle Rosenzwajg, Patrice Cacoub, Arsene Mekinian
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of interleukin-2 in treating Sjögren's syndrome in a subject, wherein IL-2 is to be administered at a low dose of less than about 3.5 MIU/day.
Claims14
A method for treating Sjögren's syndrome in a subject in need thereof, wherein the subject is administered with Interleukin-2 (IL-2) at a dose of 3.5 MIU/day or less;
- and wherein the treatment comprises at least a first course, in which the interleukin-2 is administered to the subject once per day during at least 2 or 3 consecutive days, followed by a maintenance treatment, which consists of an administration of IL-2 once or twice a week, every one or two weeks, or once a month, during a period of at least one month.
Dependencies are inferred from the claim text.